Upfront Diagnostics is discovering biomarkers to improve medical diagnosis.
Upfront Diagnostics has raised $4.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.
Upfront Diagnostics's investors include Creator Fund, Cambridge Enterprise Ventures, Stroke Association, PHOENIX SUSTAINABLE INVESTMENTS LIMITED, SBRI Healthcare.
Upfront Diagnostics is headquartered in Cambridge, United Kingdom.
Upfront Diagnostics is discovering biomarkers to improve medical diagnosis.
Upfront Diagnostics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Upfront Diagnostics — Funding & Investors." VCBacked, May 12, 2025, https://www.vcbacked.co/company/upfront-diagnostics. Accessed September 29, 2026.
VCBacked. (2025). Upfront Diagnostics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/upfront-diagnostics
{{cite web |title=Upfront Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/upfront-diagnostics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated